Corsano cooperates now with Roche Diagnostics
Corsano launched commercialization of its CardioWatch EU-MDR certified patient monitoring bracelet on cobas® pulse, a digitally enabled professional blood glucose management solution from Roche. CardioWatch 287-2 together with cobas® pulse simplifies workflows in hospital environments and equips healthcare professionals with valuable clinical insights to improve patient care.
THE HAGUE, THE NETHERLANDS, July 17, 2024 -- Corsano Health, a leading MedTech company developing, producing, and marketing medical grade continuous health monitoring announced the start of commercialization of Corsano CardioWatch on cobas® pulse from Roche.
The CardioWatch 287-2 is a wireless remote monitoring system intended for continuous collection of physiological data in healthcare and home settings. This includes Pulse Rate, SpO2, Respiration Rate, Core Body Temperature, Cuffless Blood Pressure and Arrhythmias. Data is transmitted wirelessly from the bracelet to cobas® pulse where it is made available to healthcare professionals to help inform decisions on disease management and patient care.
“Corsano Health’s CardioWatch 287-2 helps measure vital parameters accurately displaying the data on cobas® pulse devices. This enables a transformation of clinical workflows to point-of-care diagnostics, lowering overall healthcare costs, improving clinical outcomes, and enhancing the patient experience.” says Drs. Peter Stas, CEO of Corsano Health.
The cobas® pulse works together with navify® digital infrastructure solutions from Roche to create an open digital ecosystem that allows other innovations and digital health applications to be included in the hospital’s point-of-care ecosystem. The cobas® pulse is Roche’s newest generation of connected professional blood glucose management solution, designed to improve workflows and enable better patient care.More information at the cobas® pulse website.
About Corsano Health
Corsano Health, based in The Netherlands with offices in Switzerland, is a leading MedTech company that creates, manufactures, and sells advanced real-time remote patient monitoring
solutions. Corsano’s offers a CE-MDR medically certified and FDA Cleared system, enabled by the world’s most advanced multi-sensor bracelet for continuous monitoring of vital signs. Unrestricted access to raw data enables AI development to develop life-saving therapies faster. Corsano helps lower overall healthcare costs, generates unparalleled insights, improves clinical outcomes, and enhances the patient experience. The Corsano brand name is derived from in corpore sano (in a healthy body). More information at https://www.corsano.com